title: Molecular characterization of clinical isolates of Mycobacterium tuberculosis and their association with phenotypic virulence in human macrophages.
abstract: Among 125 clinical isolates of Mycobacterium tuberculosis collected in Hong Kong and Shanghai, China, between 2002 and 2004, IS6110 typing revealed that 71 strains (57%) belonged to the Beijing family. The intracellular growth of the strains in human peripheral blood monocyte-derived macrophages was measured ex vivo on days 0, 3, 6, and 10. Among all tested strains, three hypervirulent strains showed significant increases in intracellular growth after 10 days of incubation. With an initial bacterial load of 10(4) CFU, most of the clinical isolates and H37Ra (an avirulent strain) exhibited no intracellular survival on day 10, while the three hypervirulent strains together with H37Rv (a virulent strain) showed on average a two- to fourfold rise in CFU count. These three hypervirulent strains belonging to a non-Beijing family were isolated from patients suffering from tuberculosis meningitis. Cytokines secreted by gamma interferon-activated macrophages were measured daily after challenge with selected strains of M. tuberculosis. The levels of tumor necrosis factor alpha were elevated after 24 h of infection among all strains, but the levels were significantly lower among the three hypervirulent strains, whereas interleukin 10 (IL-10) and IL-12 were not detected. Results were concordant with the differential expression of the corresponding cytokine genes in activated macrophages, as monitored by real-time PCR. Our findings highlighted that these three hypervirulent strains may possess an innate mechanism for escaping host immunity, which accounts for their characteristic virulence in patients presenting with a more severe form of disease.
authors: Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong.
authors: K C
authors: KC
authors: Wong
authors: W M
authors: WM
authors: Leong
authors: H K W
authors: HK
authors: Law
authors: K F
authors: KF
authors: Ip
authors: J T H
authors: JT
authors: Lam
authors: K Y
authors: KY
authors: Yuen
authors: P L
authors: PL
authors: Ho
authors: W S
authors: WS
authors: Tse
authors: X H
authors: XH
authors: Weng
authors: W H
authors: WH
authors: Zhang
authors: S
authors: S
authors: Chen
authors: W C
authors: WC
authors: Yam
mesh_terms: D016207:Cytokines / Q000096:biosynthesis / Q000235:genetics / Q000378:metabolism; D015964:Gene Expression Regulation, Bacterial / Q000276:immunology; D006801:Humans; D008264:Macrophages / Q000276:immunology* / Q000378:metabolism / Q000382:microbiology*; D009169:Mycobacterium tuberculosis / Q000235:genetics / Q000276:immunology / Q000302:isolation & purification* / Q000472:pathogenicity*; D010641:Phenotype; D012150:Polymorphism, Restriction Fragment Length; D014774:Virulence
chemical_list: D016207:Cytokines
references: AIDS Res Ther. 2006 Mar 31;3:8
references: 16573838
references: J Clin Microbiol. 1993 Aug;31(8):1987-95
references: 7690367
references: J Immunol. 2001 Jun 15;166(12):7477-85
references: 11390501
references: Clin Microbiol Rev. 2003 Jul;16(3):463-96
references: 12857778
references: J Clin Microbiol. 1995 Dec;33(12):3234-8
references: 8586708
references: J Clin Microbiol. 1993 Feb;31(2):406-9
references: 8381814
references: Infect Immun. 1998 Jan;66(1):176-80
references: 9423855
references: Clin Exp Immunol. 2003 Jul;133(1):30-7
references: 12823275
references: Infect Immun. 2000 Jan;68(1):387-90
references: 10603413
references: N Engl J Med. 2003 Sep 18;349(12):1149-56
references: 13679530
references: Curr Opin Infect Dis. 2003 Jun;16(3):205-10
references: 12821809
references: J Immunol Methods. 2002 Jun 1;264(1-2):95-108
references: 12191514
references: J Clin Microbiol. 2002 Apr;40(4):1277-82
references: 11923345
references: J Infect Dis. 2005 Feb 1;191(3):453-60
references: 15633105
references: Clin Microbiol Rev. 2002 Apr;15(2):294-309
references: 11932234
references: Curr Opin Infect Dis. 2004 Oct;17(5):397-403
references: 15353958
references: Lancet Infect Dis. 2003 Jan;3(1):13-21
references: 12505028
references: J Clin Microbiol. 2003 Jun;41(6):2706-8
references: 12791911
references: N Engl J Med. 2001 Oct 11;345(15):1098-104
references: 11596589
references: J Clin Microbiol. 2004 Sep;42(9):4040-9
references: 15364987
references: J Clin Microbiol. 1994 Jan;32(1):262-6
references: 7907344
references: Infect Immun. 1997 Nov;65(11):4620-3
references: 9353042
references: J Infect Dis. 2000 Jul;182(1):240-51
references: 10882603
references: Infect Immun. 2004 Apr;72(4):2067-74
references: 15039328
references: J Clin Invest. 1997 May 15;99(10):2518-29
references: 9153296
references: J Immunol. 1999 Mar 15;162(6):3504-11
references: 10092807
references: Infect Immun. 1996 Apr;64(4):1351-6
references: 8606100
references: J Immunol. 2002 Feb 1;168(3):1328-37
references: 11801673
references: Infect Immun. 1998 Feb;66(2):794-9
references: 9453643
references: Int J Tuberc Lung Dis. 2002 Aug;6(8):720-7
references: 12150485